Intestinal absorption and hepatic extraction of propranolol and metoprolol in rats with bilateral ureteral ligation
- PMID: 15340230
- DOI: 10.1248/bpb.27.1422
Intestinal absorption and hepatic extraction of propranolol and metoprolol in rats with bilateral ureteral ligation
Abstract
To investigate the mechanism responsible for the increased bioavailability of propranolol in bilateral ureter-ligated (BUL) rats, the intestinal absorption and hepatic extraction of propranolol and metoprolol were evaluated. The initial absorption rate of these drugs after intra-intestinal administration was only slightly increased in the BUL rats, whereas the blood drug concentration in these rats was higher than that in control rats. The blood propranolol and metoprolol concentrations during intra-portal infusion in the BUL rat were significantly higher than that in the control rat. In the presence of NADPH, the intrinsic metabolic activity of metoprolol in hepatic microsomes was not altered by BUL. On the other hand, the NADPH generation rate in the hepatic cytosol in the BUL group was lower than that in the control group. These results indicate that the absorption rate-dependent decrease in hepatic first-pass clearance of propranolol and metoprolol due to saturation kinetics is marginal, and that the hepatic metabolic activity and extraction of the drugs is significantly decreased in BUL rats probably due to the reduced NADPH generation rate in the liver.
Similar articles
-
Endogenous uremic substances are not involved in the reduced hepatic extraction of metoprolol in bilateral ureter-ligated rats.Drug Metab Pharmacokinet. 2006 Apr;21(2):156-64. doi: 10.2133/dmpk.21.156. Drug Metab Pharmacokinet. 2006. PMID: 16702736
-
Mechanism responsible for the decreased hepatic NADPH generation rate in rats with bilateral ureter ligation-induced renal failure.Biol Pharm Bull. 2005 Sep;28(9):1809-12. doi: 10.1248/bpb.28.1809. Biol Pharm Bull. 2005. PMID: 16141568
-
Pharmacokinetics and hepatic extraction of metoprolol in rats with glycerol-induced acute renal failure.Biol Pharm Bull. 2007 Mar;30(3):552-5. doi: 10.1248/bpb.30.552. Biol Pharm Bull. 2007. PMID: 17329855
-
[Beta blockers in migraine prophylaxis].Brain Nerve. 2009 Oct;61(10):1125-30. Brain Nerve. 2009. PMID: 19882938 Review. Japanese.
-
[Effect of liver cirrhosis on pharmacokinetics and pharmacodynamics of drugs].Vnitr Lek. 2013 Jul;59(7):584-6. Vnitr Lek. 2013. PMID: 23909263 Review. Czech.
Cited by
-
Spheroid Size Does not Impact Metabolism of the β-blocker Propranolol in 3D Intestinal Fish Model.Front Pharmacol. 2018 Aug 22;9:947. doi: 10.3389/fphar.2018.00947. eCollection 2018. Front Pharmacol. 2018. PMID: 30186177 Free PMC article.
-
Effect of chronic hypoxic hypoxia on oxidation and glucuronidation of carvedilol in rats.Eur J Drug Metab Pharmacokinet. 2014 Mar;39(1):53-9. doi: 10.1007/s13318-013-0140-2. Epub 2013 Jun 6. Eur J Drug Metab Pharmacokinet. 2014. PMID: 23739952
-
Radiation preparation of L-arginine/acrylic acid hydrogel matrix patch for transdermal delivery of propranolol HCl in hypertensive rats.Drug Deliv Transl Res. 2018 Jun;8(3):525-535. doi: 10.1007/s13346-017-0468-2. Drug Deliv Transl Res. 2018. PMID: 29313295
-
Consequences of renal failure on non-renal clearance of drugs.Clin Pharmacokinet. 2014 Jun;53(6):521-32. doi: 10.1007/s40262-014-0146-1. Clin Pharmacokinet. 2014. PMID: 24861189 Review.
-
Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism.Int J Mol Sci. 2014 Feb 13;15(2):2538-53. doi: 10.3390/ijms15022538. Int J Mol Sci. 2014. PMID: 24531139 Free PMC article. Review.